Anika reports inducement grants under nasdaq listing rule 5635(c)(4)

Bedford, mass., dec. 10, 2021 (globe newswire) -- anika therapeutics, inc. (nasdaq: anik), a global joint preservation company in early intervention orthopedics, today announced that on december 1, 2021, anika granted non-statutory stock options covering an aggregate of 1,069 shares of common stock (the “options”) and restricted stock units (the “rsus”) covering an aggregate of 468 shares of common stock to 1 newly hired non-executive employee. each grant was made pursuant to the anika therapeutics, inc. 2021 inducement plan, was approved by the compensation committee of the board of directors pursuant to a delegation of authority by the board of directors, and, in accordance with nasdaq listing rule 5635(c)(4), was made as a material inducement to the grantee's acceptance of employment with anika as a component of the grantee's employment compensation.
ANIK Ratings Summary
ANIK Quant Ranking